AGP Picks
View all

California Health Watch
Provided by AGP

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

August 2026

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31

September 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30

Press releases published on September 14, 2026

ANGELIS Oncology launches, acquires PLX038, and initiates clinical trial in glioblastoma.
Sep. 14, 2026

ANGELIS Oncology launches, acquires PLX038, and initiates clinical trial in glioblastoma.

Indeterminate EIN Presswire
Vermont Urgent Care Hosting Free Vermont Day 'Salud & Care Festival' for Los Angeles Families on September 19
Sep. 14, 2026

Vermont Urgent Care Hosting Free Vermont Day 'Salud & Care Festival' for Los Angeles Families on September 19

Indeterminate EIN Presswire
Dr. Lamia Gabal Brings Rare Dual Urology-Pelvic Medicine Certification to OC
Sep. 14, 2026

Dr. Lamia Gabal Brings Rare Dual Urology-Pelvic Medicine Certification to OC

Indeterminate EIN Presswire
Elizabeth M. Lykins Challenges People to Look Within for the Change They Want
Sep. 14, 2026

Elizabeth M. Lykins Challenges People to Look Within for the Change They Want

Indeterminate EIN Presswire
Patients Can’t Wait: Growing Coalition of Patients and Families Back Prop 38 to Advance Life-Saving Medical Research
Sep. 14, 2026

Patients Can’t Wait: Growing Coalition of Patients and Families Back Prop 38 to Advance Life-Saving Medical Research

Indeterminate EIN Presswire
Heartseed Advances Regenerative Cell Therapy Approaches for Severe Heart Failure
Sep. 14, 2026

Heartseed Advances Regenerative Cell Therapy Approaches for Severe Heart Failure

Indeterminate EIN Presswire
EvolveWare Recognized in the Inaugural Gartner® Magic Quadrant™ for AI-Augmented Code Modernization Tools
Sep. 14, 2026

EvolveWare Recognized in the Inaugural Gartner® Magic Quadrant™ for AI-Augmented Code Modernization Tools

Indeterminate EIN Presswire
PGxAI’s Andromeda Outperforms Frontier AI Labs at Clinical Prescribing Guidance
Sep. 14, 2026

PGxAI’s Andromeda Outperforms Frontier AI Labs at Clinical Prescribing Guidance

Indeterminate EIN Presswire
MUSE Microscopy Appoints PathGroup Founder and Co-Chairman Dr. Ben W. Davis to Board of Directors
Sep. 14, 2026

MUSE Microscopy Appoints PathGroup Founder and Co-Chairman Dr. Ben W. Davis to Board of Directors

Indeterminate EIN Presswire
Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Sep. 14, 2026

Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager
Sep. 14, 2026

From Former Patient to Clinical Leader: Oxford Treatment Center Promotes Kate Bell to Outpatient Clinical Manager

Indeterminate GlobeNewswire
Radiology Associates of San Luis Obispo Joins Strategic Radiology, Strengthening Coalition’s Presence in California
Sep. 14, 2026

Radiology Associates of San Luis Obispo Joins Strategic Radiology, Strengthening Coalition’s Presence in California

Indeterminate EIN Presswire
Ascendis Announces Planned $400 Million Share Repurchase Program
Sep. 14, 2026

Ascendis Announces Planned $400 Million Share Repurchase Program

Indeterminate GlobeNewswire
Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases
Sep. 14, 2026

Ascendis to Regain Rights to TransCon® Technology in Metabolic and Cardiovascular Diseases

Indeterminate GlobeNewswire
Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs
Sep. 14, 2026

Curium™ announces FDA approval of BEXLUTRY lutetium Lu 177 dotatate injection for adults with SSTR-positive GEP-NETs

Indeterminate GlobeNewswire
Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards
Sep. 14, 2026

Onspire Health Marketing Clients Earn Five Gold Healthcare Advertising Awards

Indeterminate GlobeNewswire
DLH Appoints Brooke Pierce President of Health Business Group
Sep. 14, 2026

DLH Appoints Brooke Pierce President of Health Business Group

Indeterminate GlobeNewswire
Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study
Sep. 14, 2026

Agomab Announces Positive Phase 1 Results for AGMB-447 in Patients with Idiopathic Pulmonary Fibrosis and Design of Phase 2 INSPIRIA Study

Indeterminate GlobeNewswire
PetMeds Appoints Andrew Parry as Chief Technology Officer
Sep. 14, 2026

PetMeds Appoints Andrew Parry as Chief Technology Officer

Indeterminate GlobeNewswire
Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer
Sep. 14, 2026

Revolution Medicines Announces U.S. FDA Breakthrough Therapy Designation for RASONQUE™ (daraxonrasib) in Combination with Chemotherapy for First Line Metastatic Pancreatic Cancer

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

California Health Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.